Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study.

Hauser S, Kogej M, Fechner G, VON Pezold J, Vorreuther R, Lümmen G, Müller SC, Ellinger J.

Anticancer Res. 2013 Mar;33(3):779-84.

PMID:
23482744
2.

Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study.

Hauser S, Zahalka T, Fechner G, Müller SC, Ellinger J.

Anticancer Res. 2013 Oct;33(10):4651-6.

PMID:
24123044
3.

Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.

Ellinger J, El Kassem N, Heukamp LC, Matthews S, Cubukluoz F, Kahl P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ.

J Urol. 2008 Jan;179(1):346-52. Epub 2007 Nov 19.

PMID:
18006010
4.

Cell-free serum DNA in patients with bladder cancer: results of a prospective multicenter study.

Hauser S, Kogej M, Fechner G, Von Ruecker A, Bastian PJ, Von Pezold J, Vorreuther R, Lümmen G, Müller SC, Ellinger J.

Anticancer Res. 2012 Aug;32(8):3119-24.

PMID:
22843882
5.

Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.

Matuschek C, Bölke E, Lammering G, Gerber PA, Peiper M, Budach W, Taskin H, Prisack HB, Schieren G, Orth K, Bojar H.

Eur J Med Res. 2010;15:277-86.

6.

Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine.

Chen PC, Tsai MH, Yip SK, Jou YC, Ng CF, Chen Y, Wang X, Huang W, Tung CL, Chen GC, Huang MM, Tong JH, Song EJ, Chang DC, Hsu CD, To KF, Shen CH, Chan MW.

BMC Med Genomics. 2011 May 20;4:45. doi: 10.1186/1755-8794-4-45.

7.

CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.

Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.

Prostate. 2008 Jan 1;68(1):42-9.

PMID:
18004747
8.

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.

Dulaimi E, Uzzo RG, Greenberg RE, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Mar 15;10(6):1887-93.

9.

CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.

Ellinger J, Albers P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ.

J Urol. 2009 Jul;182(1):324-9. doi: 10.1016/j.juro.2009.02.106. Epub 2009 May 17.

PMID:
19447423
10.

Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection.

Lin HH, Ke HL, Wu WJ, Lee YH, Chang LL.

Urol Oncol. 2012 Mar-Apr;30(2):177-81. doi: 10.1016/j.urolonc.2010.01.002. Epub 2010 Aug 25.

PMID:
20800513
11.

DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.

Negraes PD, Favaro FP, Camargo JL, Oliveira ML, Goldberg J, Rainho CA, Salvadori DM.

BMC Cancer. 2008 Aug 14;8:238. doi: 10.1186/1471-2407-8-238.

12.

Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.

Ellinger J, Müller DC, Müller SC, Hauser S, Heukamp LC, von Ruecker A, Bastian PJ, Walgenbach-Brunagel G.

Urol Oncol. 2012 Jul-Aug;30(4):509-15. doi: 10.1016/j.urolonc.2010.03.004. Epub 2010 Sep 26.

PMID:
20870429
13.

Assessing the use of p16(INK4a) promoter gene methylation in serum for detection of bladder cancer.

Valenzuela MT, Galisteo R, Zuluaga A, Villalobos M, Núñez MI, Oliver FJ, Ruiz de Almodóvar JM.

Eur Urol. 2002 Dec;42(6):622-8; discussion 628-30.

PMID:
12477660
14.

Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.

Phé V, Cussenot O, Rouprêt M.

BJU Int. 2009 Oct;104(7):896-901. doi: 10.1111/j.1464-410X.2009.08696.x. Epub 2009 Jun 12. Review.

15.

p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.

Kawamoto K, Enokida H, Gotanda T, Kubo H, Nishiyama K, Kawahara M, Nakagawa M.

Biochem Biophys Res Commun. 2006 Jan 20;339(3):790-6. Epub 2005 Nov 22.

PMID:
16316628
16.

Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential.

Patchsung M, Boonla C, Amnattrakul P, Dissayabutra T, Mutirangura A, Tosukhowong P.

PLoS One. 2012;7(5):e37009. doi: 10.1371/journal.pone.0037009. Epub 2012 May 15.

17.

Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity.

Ellinger J, Bastian PJ, Ellinger N, Kahl P, Perabo FG, Büttner R, Müller SC, Ruecker Av.

Cancer Lett. 2008 Jun 18;264(2):274-80. doi: 10.1016/j.canlet.2008.01.038. Epub 2008 Mar 10.

PMID:
18329789
18.

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93.

19.

Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.

Jarmalaite S, Jankevicius F, Kurgonaite K, Suziedelis K, Mutanen P, Husgafvel-Pursiainen K.

Oncology. 2008;75(3-4):145-51. doi: 10.1159/000158665. Epub 2008 Sep 29.

PMID:
18824877
20.

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.

Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D.

J Natl Cancer Inst. 2006 Jul 19;98(14):996-1004.

Items per page

Supplemental Content

Write to the Help Desk